Eton PharmaceuticalsETON
13F holders, Q1 2024 (March 31)44holders
2famous investors
$3.75avg. 13F price*
At the end of Q1 2024, 44 institutions reported holding Eton Pharmaceuticals Inc. (ETON) in their 13F filings. The largest holders were Opaleye Management Inc. ($9.2M), Vanguard Group Inc. ($3.9M) and Acuitas Investments, LLC ($2.2M). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Eton Pharmaceuticals Inc.
- CUSIP
- 29772L108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $518K |
| Exits | 13 | $1.4M |
Ownership 44 holders
| Opaleye Management Inc. | 2.01% | Reduce -3.3% | 2,445,781 | $9.2M |
| Vanguard Group Inc. | 0.00% | No change | 1,027,688 | $3.9M |
| Acuitas Investments, LLC | 1.10% | Add +17.9% | 579,960 | $2.2M |
| Westside Investment Management, Inc. | 0.52% | Add +1.9% | 573,960 | $2.2M |
| National Philanthropic Trust | 0.04% | No change | 492,112 | $1.8M |
| Paradigm Capital Management Inc. | 0.05% | No change | 300,000 | $1.1M |
| BlackRock Inc. | 0.00% | Reduce -0.5% | 282,952 | $1.1M |
| Bridgeway Capital Management, LLC | 0.02% | No change | 253,362 | $950K |
| Geode Capital Management, LLC | 0.00% | Add +3.0% | 234,167 | $878K |
| Susquehanna International Group, LLP | 0.00% | Add +921.6% | 199,219 | $747K |
| Parkman Healthcare Partners LLC | 0.09% | No change | 199,168 | $747K |
| Acadian Asset Management LLC | 0.00% | Add +13.8% | 156,386 | $585K |
| Goldman Sachs Group Inc. | 0.00% | New | 118,855 | $446K |
| Schonfeld Strategic Advisors LLC | 0.00% | Add +66.1% | 96,869 | $363K |
| State Street Corp. | 0.00% | No change | 81,403 | $305K |
| Essex Investment Management Co. LLC | 0.06% | No change | 78,613 | $295K |
| Bank of New York Mellon Corp | 0.00% | Reduce -6.2% | 74,491 | $279K |
| Renaissance Technologies | 0.00% | Add +52.3% | 65,031 | $244K |
| Northern Trust Corp. | 0.00% | Reduce -5.4% | 61,130 | $229K |
| Squarepoint Ops LLC | 0.00% | Reduce -22.6% | 49,093 | $184K |
| Qube Research & Technologies Ltd | 0.00% | Reduce -11.6% | 44,614 | $167K |
| Connor, Clark & Lunn Investment Management Ltd. | 0.00% | Reduce -8.8% | 39,297 | $147K |
| Blair William & Co. | 0.00% | No change | 36,979 | $139K |
| Two Sigma Investments, LP | 0.00% | Reduce -39.5% | 31,790 | $119K |
| Jane Street Group, LLC | 0.00% | Add +25.2% | 23,078 | $87K |
| JPMorgan Chase & Co. | 0.00% | New | 19,155 | $72K |
| Two Sigma Advisers, LP | 0.00% | Add +62.4% | 17,700 | $66K |
| CHICAGO TRUST Co NA | 0.01% | No change | 16,700 | $63K |
| XTX Topco Ltd | 0.01% | Reduce -38.3% | 14,103 | $53K |
| Charles Schwab Investment Management Inc. | 0.00% | No change | 13,239 | $50K |
| Quantum Private Wealth, LLC | 0.02% | No change | 11,500 | $43K |
| Dimensional Fund Advisors LP | 0.00% | No change | 10,564 | $40K |
| Raymond James & Associates | 0.00% | Add +1.5% | 10,250 | $38K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +86.9% | 7,593 | $28K |
| UBS Group AG | 0.00% | Reduce -47.8% | 1,960 | $7K |
| Truvestments Capital LLC | 0.00% | No change | 1,848 | $7K |
| Wells Fargo & Company | 0.00% | Add +728.5% | 1,425 | $5K |
| Plante Moran Financial Advisors, LLC | 0.00% | No change | 1,000 | $4K |
| Royal Bank of Canada | 0.00% | Reduce -70.9% | 765 | $3K |
| Lazard Asset Management LLC | 0.00% | Reduce -47.3% | 576 | $2K |
| BNP Paribas Financial Markets | 0.00% | No change | 350 | $1K |
| Morgan Stanley | 0.00% | No change | 38 | $143 |
| Citadel Advisors | 0.00% | Reduce -99.3% | 32 | $120 |
| Lindbrook Capital, LLC | 0.00% | No change | 4 | $15 |
"% of holder's portfolio" is ETON's weight in each manager's 13F, not the share of Eton Pharmaceuticals Inc. the manager owns.